Skip to content

Clinical trials

Recruiting Alzheimer Disease trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Status: Recruiting Country / region: China Clear all

88 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20051
20061
20121
20181
20192
20206
20213
20225
20235
202419
202525
202618

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting88

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Xuanwu Hospital, Beijing8
Capital Medical University5
Ruijin Hospital4
Tianjin Medical University4
First Affiliated Hospital of Zhejiang University3
Anhui Medical University2
Beijing Tiantan Hospital2
Bristol-Myers Squibb2
Chinese PLA General Hospital2
Eli Lilly and Company2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease88
Cognitive Dysfunction21
Dementia8
Nervous System Diseases3
Neurodegenerative Diseases3
Parkinson Disease3
Amyloid Neuropathies, Familial2
Amyloidosis2
Asthenia2
Brain Neoplasms2

Trials

Showing 1 to 25 of 88. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.